Table 2.

ORs and 95% CIs of the association between ACE I/D polymorphism and glioma risk

Model	Cases (n)	Controls (n)	OR	p
Homozygous co-dominant: DD vs II
DD	23	66	2.43 (0.51-11.55)	0.24
II	2	14
Heterozygous co-dominant: ID vs II
ID	11	115	0.66 (0.13 -3.33)	0.62
II	2	14
Heterozygous co-dominant: DD vs ID
DD	23	66	3.64 (1.67-7.94)	<0.001
ID	11	115
Dominant model: (DD + ID) vs II
DD + ID	34	181	1.31 (0.28-6.04)	0.7
II	2	14
Recessive model: (II + ID) vs DD
II + ID	13	129	0.28 (0.13-0.60)	<0.001
DD	23	66
Allele model
D	57	247	2.20 (1.20-4.02)	0.009
I	15	143